Thyroid Hormone Interacts With the Wnt/β-Catenin Signaling Pathway in the Terminal Differentiation of Growth Plate Chondrocytes
- 1 December 2007
- journal article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 22 (12) , 1988-1995
- https://doi.org/10.1359/jbmr.070806
Abstract
Thyroid hormone activates Wnt-4 expression and Wnt/beta-catenin signaling in rat growth plate chondrocytes. Wnt antagonists Frzb/sFRP3 and Dkk1 inhibit T3-induced Wnt/beta-catenin activation and inhibit the maturation-promoting effects of T3 in growth plate cells. This study indicates that thyroid hormone regulates terminal differentiation of growth plate chondrocytes in part through modulating Wnt/beta-catenin signaling. Thyroid hormone is a potent regulator of skeletal maturation in the growth plate, yet the molecular mechanisms underlying this profound effect remain unknown. Wnt signaling has recently been recognized as an important signal transduction pathway in regulating chondrogenesis and terminal differentiation of growth plate chondrocytes. The objective of this study was to explore the interaction between the thyroid hormone and Wnt signaling pathways in the growth plate. Rat epiphyseal chondrocytes were maintained in 3D pellet culture and treated with triiodothyronine (T3). Activation of Wnt/beta-catenin signaling pathway in response to T3 was detected by measurement of the expression of Wnt-4 mRNA, the cellular accumulation of beta-catenin, the transcriptional activity of TCF/LEF, and the expression of the Wnt/beta-catenin responsive gene Runx2/cbfa1. Terminal differentiation of the chondrocytes was assessed by measurement of alkaline phosphatase enzymatic activity and Col10a1 gene expression. Thyroid hormone treatment of growth plate chondrocytes upregulated both Wnt-4 mRNA and protein expression, increased cellular accumulation of stabilized beta-catenin, increased TCF/LEF transcriptional activity, and stimulated the expression of the Runx2/cbfa1 gene. Overexpression of either Wnt-4 or a stabilized form of beta-catenin promoted growth plate chondrocyte terminal differentiation. Blocking Wnt ligand/receptor interactions with the secreted Wnt antagonists Frzb/sFRP3 or Dkk1 inhibited these T3-induced increases in beta-catenin accumulation and Runx2 gene expression and inhibited the maturation-promoting effects of T3 in growth plate cells. These data suggest that thyroid hormone regulates terminal differentiation of growth plate chondrocytes in part through modulating canonical Wnt/beta-catenin signaling.Keywords
This publication has 22 references indexed in Scilit:
- Wnt‐mediated regulation of chondrocyte maturation: Modulation by TGF‐βJournal of Cellular Biochemistry, 2005
- THE WNT SIGNALING PATHWAY IN DEVELOPMENT AND DISEASEAnnual Review of Cell and Developmental Biology, 2004
- LRP5 and Wnt Signaling: A Union Made for BoneJournal of Bone and Mineral Research, 2004
- Interactions between Sox9 and β-catenin control chondrocyte differentiationGenes & Development, 2004
- Secreted antagonists of the Wnt signalling pathwayJournal of Cell Science, 2003
- Secreted Frizzled‐related proteins: searching for relationships and patternsBioEssays, 2002
- Silencing of Wnt Signaling and Activation of Multiple Metabolic Pathways in Response to Thyroid Hormone-Stimulated Cell ProliferationMolecular and Cellular Biology, 2001
- Efficient lipid-mediated gene transfer to articular chondrocytesGene Therapy, 2000
- Thyroxine is the serum factor that regulates morphogenesis of columnar cartilage from isolated chondrocytes in chemically defined medium.The Journal of cell biology, 1994
- Thyroxine and the development of the tibia in the embryonic chickThe Anatomical Record, 1973